DISHMAN PHARMA Fact Sheet, DISHMAN PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA Fact Sheet    (DHPH)


Latest: Richa Agarwal's Top 3 Stocks for 2022 Revealed


Here is the latest financial fact sheet of DISHMAN PHARMA. For more details, see the DISHMAN PHARMA quarterly results and DISHMAN PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

DISHMAN PHARMA Price History

Price Rs 301.1
Mkt Cap Rs m 48,588
Vol '000 460.5
P/E X 30.0
P/CF X 17.3
EPS (TTM) Rs 10.0
1 Day % 2.9
No. of shares m 161.39
1 Week % 3.5
1 Month % -2.4
1 Year % 96.4
52 week H/L Rs 346.3/127.6
As on May 29, 2017 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DISHMAN PHARMA Financials

No. of Mths
Year Ending
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
DISHMAN PHARMA EQUITY SHARE DATA
High Rs107122107183374 
Low Rs35423983129 
Sales per share (Unadj.) Rs138.6157.0171.0196.0197.0 
Earnings per share (Unadj.) Rs7.012.413.514.821.2 
Diluted earnings per shareRs3.56.26.87.410.6 
Cash flow per share (Unadj.) Rs16.522.827.033.534.7 
Dividends per share (Unadj.) Rs1.201.201.202.002.00 
Adj. dividends per shareRs0.600.600.601.001.00 
Avg Dividend yield %1.71.51.61.50.8 
Book value per share (Unadj.) Rs115.1127.7145.9153.4179.9 
Adj. book value per shareRs57.663.972.976.789.9 
Shares outstanding (eoy) m80.7080.7080.7080.7080.70 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x0.50.50.40.71.3 
Avg P/E ratio x10.16.65.48.911.9 
P/CF ratio (eoy) x4.33.62.74.07.3 
Price / Book Value ratio x0.60.60.50.91.4 
Dividend payout %17.19.78.913.59.4 
Avg Mkt Cap Rs m5,7296,6175,90310,69220,307 
No. of employees `000NANANANANA 
Total wages/salary Rs m2,9413,5094,1234,2325,355 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
DISHMAN PHARMA INCOME DATA
Net Sales Rs m11,18312,66613,79815,81515,898 
Other income Rs m129178249869265 
Total revenues Rs m11,31312,84514,04816,68416,163 
Gross profit Rs m2,2452,9013,3213,1274,103 
Depreciation Rs m7658381,0861,5071,091 
Interest Rs m729788921897944 
Profit before tax Rs m8791,4531,5641,5922,334 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m312450471394624 
Profit after tax Rs m5681,0031,0931,1981,710 
Gross profit margin %20.122.924.119.825.8 
Effective tax rate %35.431.030.124.826.7 
Net profit margin %5.17.97.97.610.8 
DISHMAN PHARMA BALANCE SHEET DATA
Current assets Rs m6,3236,7338,24510,13511,018 
Current liabilities Rs m6,6317,1279,02811,0489,517 
Net working cap to sales %-2.8-3.1-5.7-5.89.4 
Current ratio x1.00.90.90.91.2 
Inventory Days Days5743584957 
Debtors Days Days61021038153 
Net fixed assets Rs m16,25116,17818,03217,95418,787 
Share capital Rs m161161161161161 
"Free" reserves Rs m9,12710,14711,61112,21714,354 
Net worth Rs m9,28810,30811,77212,37814,516 
Long term debt Rs m5,1214,3364,1213,3024,189 
Total assets Rs m22,57422,91126,27728,08929,805 
Interest coverage x2.22.82.72.83.5 
Debt to equity ratio x0.60.40.40.30.3 
Sales to assets ratio x0.50.60.50.60.5 
Return on assets %5.77.87.77.58.9 
Return on equity %6.19.79.39.711.8 
Return on capital %11.215.315.615.917.5 
Exports to sales %30.428.427.922.724.9 
Imports to sales %6.54.66.35.53.7 
Exports (fob) Rs m3,4043,5953,8553,5983,956 
Imports (cif) Rs m728581865870594 
Fx inflow Rs m3,9744,2103,9664,5764,952 
Fx outflow Rs m905695954974697 
Net fx Rs m3,0693,5153,0113,6014,255 
DISHMAN PHARMA CASH FLOW
From Operations Rs m 1,536 1,651 3,445 2,937 2,786 
From Investments Rs m -1,040 -1,173 -2,568 -1,581 -1,529 
From Financial Activity Rs m -680 -501 -741 -1,420 -941 
Net Cashflow Rs m -185 -23 136 -64 317 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 61.4%
Institution 20.8%
Non-Institution 17.8%
Total 100.0%
Free Float 38.6%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2017
 

Company Information

Regd Off Bhadr Raj Chambers, Swastik Cross Road, Navrangpura, Ahmedabad - 380009
E-mail dishman@dishmangroup.com Web www.dishmangroup.com
Tel 079- 26443053 / 26445807 / 26560089 Fax 079- 26420198
Sector PHARMACEUTICALS Group Dishman Pharma
Tr Agent Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
Auditor Deloitte Haskins & Sells
CHM: Janmejay R Vyas COMP SEC: Shrima G Dave YEAR OF INC: 1983 BSE CODE: 532526 FV (Rs): 2 DIV YIELD (%): 0.3

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    

Compare DISHMAN PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    




Today's Market

4 Reasons Why Sensex Rallied 1,345 Points Today(Closing)

After opening the day higher, Indian share markets extended gains as the session progressed and ended near the day's high.

Views on news

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

IPO Alert! 3 Companies Including PharmEasy Get the Green Light (Views On News)

Feb 22, 2022

The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far... (Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022 (Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022 (Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look... (Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better? (Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DISHMAN PHARMA

  • Track your investment in DISHMAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN PHARMA

DISHMAN PHARMA - TEVA PHARMA COMPARISON

COMPARE DISHMAN PHARMA WITH

MARKET STATS